Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis

NCT ID: NCT04012216

Last Updated: 2024-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

55 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-28

Study Completion Date

2024-11-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The general aim of this study is to demonstrate that the measurement of respiratory effort assessed by mandibular movements during sleep is a useful measure for the screening of sleep disordered breathing (SDB) in patients with moderate to severe persistent rhinitis (R). The primary objective is therefore to determine a mandibular movement respiratory disturbance index (MM-RDI) threshold associated with a polysomnography respiratory disturbance index (PSG-RDI) ≥ 15 / h in a population of patients with moderate-to-severe persistent R.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives of the study are to evaluate the concordance and correlation between:

* MM-RDI,
* the respiratory effort evaluated by MM,
* polysomnography (PSG) results,
* quality of life questionnaires,
* clinical data,
* treatments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The study population

Patients consulting for persistant, moderate-to-severe rhinitis and meeting eligibility criteria.

Measure of mandibular movement using a mid-sagittal magnetic sensor (Brizzy, Jawac©) Nomics, Liege, Belgium)

Intervention Type DEVICE

A mid-sagittal MM magnetic sensor (Brizzy, Jawac©) Nomics, Liege, Belgium) measures the distance in mm between two parallel, coupled, resonant circuits placed on the forehead and on the chin. Measurements last one night.

Gold standard: polysomnography

Intervention Type DEVICE

Polysomnography will be performed according to the American Academy of Sleep Medicine Recommendations 2018

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measure of mandibular movement using a mid-sagittal magnetic sensor (Brizzy, Jawac©) Nomics, Liege, Belgium)

A mid-sagittal MM magnetic sensor (Brizzy, Jawac©) Nomics, Liege, Belgium) measures the distance in mm between two parallel, coupled, resonant circuits placed on the forehead and on the chin. Measurements last one night.

Intervention Type DEVICE

Gold standard: polysomnography

Polysomnography will be performed according to the American Academy of Sleep Medicine Recommendations 2018

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient consulting for persistant, moderate-to-severe rhinitis
* The patient has signed the informed consent
* The patient is a beneficiary of a social security programme (national health insurance)
* Patient living in the Montpellier region (\< 30 kilometers).

Exclusion Criteria

* The patient is participating in another study that precludes participation in the present study
* The patient is in an exclusion period determined by another study
* It is impossible to correctly inform the patient
* The patient cannot fluently read French
* Vulnerable patient populations according to French Health Code article L1121-6
* Adult under guardianship or incapable of giving consent according to French Health Code article L1121-8
* Pregnancy, breastfeeding (French Health Code article L1121-5)
* Any element that renders participation in the study problematic according to the investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ADENE

UNKNOWN

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dany JAFFUEL, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Respiratory Medicine and Addiction Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Montpellier

Montpellier, Hérault, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL18_0473

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.